Navigation Links
Blood-Thinner Contaminant Traced to Chinese Plant
Date:3/14/2008

As a result, FDA to require testing of all imported heparin

FRIDAY, March 14 (HealthDay News) -- The contaminant found in the blood-thinner heparin, which has been linked to hundreds of allergic reactions and possibly 19 deaths in the United States, has been traced to a Chinese plant that processed raw ingredients for the drug, U.S. health officials said Friday.

As a result, the U.S. Food and Drug Administration said it will start testing all heparin products to be imported into the United States. The announcement comes as the agency continues its investigation into the contamination with heparin produced by Baxter Healthcare Corp., of Deerfield, Ill.

The heparin was supplied to Baxter by Scientific Protein Laboratories of Waunakee, Wisc., and its Changzhou SPL plant in Changzhou City, China. The company is Baxter's main supplier of the active pharmaceutical ingredient in heparin.

"The active pharmaceutical ingredient comes from the Changzhou SPL plant in China," Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said during an afternoon teleconference.

"The FDA conducted an inspection in this plant, and we obtained 28 samples of the active pharmaceutical ingredient," Woodcock said. "We found 20 of these samples had a heparin-like contaminant."

In light of the finding, the FDA has placed the Changzhou SPL plant on "import alert," Woodcock said, meaning the plant has agreed not to export any more heparin to the United States.

In a statement released late Friday, Baxter said its staffers "have been working seven days a week since late December 2007" trying to determine the nature of the contaminant. The company has so far ruled out a number of infectious pathogens, dioxins or the pufferfish toxin (tetrodoxin).

"While Baxter's analysis is not complete, the company has evidence that the unknown material is a highly sulfated glucosaminoglyca
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Mix-Up Behind FDAs Failure to Inspect China Blood-Thinner Plant
2. New findings on emerging contaminants
3. Large source of nitrate, a potential water contaminant, found in near-surface desert soils
4. FDA Finds Contaminant in Baxters Recalled Heparin Products
5. Salmonella Outbreak Traced to Banquet and Store Brand Frozen Pot Pies
6. Colon cancer risk in US traced to common ancester
7. Some cases of autism may be traced to the immune system of mothers during pregnancy
8. High alcohol consumption increases stroke risk among Chinese men
9. Heavy Drinking Boosts Stroke Risk for Chinese Men
10. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
11. Chinese takeaway in the Wadden Sea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013 According to a May 14, ... More Options for Breast Cancer Surgery,” modern medical technology has ... approach this disease in a whole new light. Since the ... now face breast cancer and mastectomies with greater ... “Before the introduction of plastic surgery to oncology, women had ...
(Date:5/22/2013)... next two decades, the cost of treating strokes in ... topping more than $180 billion a year, according to ... an aging population. The report, from the American Heart ... May 22 in the journal Stroke . ... Bruce Ovbiagele, chairman of the department of neurology at ...
(Date:5/22/2013)... 22, 2013 Recent tragedies including ... the school shooting in Newtown, Connecticut all resulted ... , Emergency medical practitioners train to respond ... Emergency Medical Services for Children (EMSC) Program specifically ... for the youngest patients. It is estimated 30 ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 HR Strategies ... hosted at the Gwinnett County Fairgrounds, on Friday May ... before, they far surpassed expectations; raising over $6,300 for ... sponsor for the event, donating the first $3,000 for ... , challenged the internal staff to match the company’s ...
(Date:5/22/2013)... Alan Mozes HealthDay Reporter , , WEDNESDAY, May ... number of American children who die each year awaiting ... research reveals. And increasing numbers of children are receiving ... of potential organ donors expanded to include not just ... a "circulatory determination of death." But it,s unclear ...
Breaking Medicine News(10 mins):Health News:Breast Augmentation – New Option for Breast Cancer Surgeries 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care 2Health News:HR Strategies Raises Over $6,300 for Cancer Research via Relay For Life 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 2Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 3Health News:More Kids Getting Donor Organs, But Gaps Persist, Study Finds 4
... SALT LAKE CITY, Jan. 5 Health-conscious consumers who ... day now have a smaller,more powerful alternative to fish ... MegaRed delivers essential omega-3 fatty acids combined with,powerful antioxidants, ... supporting,heart health. One MegaRed softgel per day -- which ...
... VIEW, Calif., Jan. 5 Based on its ... Sullivan recognizes Toshiba,America Medical Systems with the 2008 ... The company has launched a variety of,cardiovascular imaging ... cardiac ultrasound line. This product has taken,echocardiography a ...
... Treat Diseases (HTDS) www.htdsmedical.com Further to the ... company addressed several targeted merger candidates, the company is ... negotiations with Slavica Bio Chem, www.slavicabiochem.com (Slavica). ... Renuyu Biochem, a USA and a UK company, founded ...
... IRVING, Texas, Jan. 5 RBC Life Sciences ... has elected current president, John W. Price, to CEO ... is currently CEO, will remain as chairman of the ... RBC Life Sciences, a global provider of proprietary nutritional ...
... Licenses PDL,s Queen et al. Patents for Soliris(R) INCLINE VILLAGE, ... (Nasdaq: PDLI ) and Alexion Pharmaceuticals, Inc. ... the companies have entered into a definitive license agreement and ... to Alexion,s humanized antibody, Soliris(R) (eculizumab) and PDL,s patents known ...
... Jan. 5 The Ensign Group, Inc. (Nasdaq: ... has acquired Southland Healthcare Center, a 150-bed skilled ... effective January 1, 2009. The facility has been ... http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO )"This is a strategic acquisition, and ...
Cached Medicine News:Health News:Three Times More Powerful Than Fish Oil, MegaRed(TM) Omega-3 Krill Oil Now Available Nationwide 2Health News:Three Times More Powerful Than Fish Oil, MegaRed(TM) Omega-3 Krill Oil Now Available Nationwide 3Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 2Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 3Health News:Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services 4Health News:Hard To Treat Diseases (HTDS) Completes E Europe Merger 2Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 2Health News:RBC Life Sciences Promotes Industry Veteran John W. Price to CEO; Company Founder, Clinton Howard, Will Remain Chairman of the Board 3Health News:Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute 2Health News:Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute 3Health News:The Ensign Group Acquires Texas Skilled Nursing Facility 2
(Date:5/22/2013)... May 22, 2013 Ranbaxy Laboratories Limited ... Ltd. (hereafter, Daiichi Sankyo), announced on May 22 ... years to address past conduct under prior management ... Daiichi Sankyo continues to support Ranbaxy in ... of the past which led to the investigations ...
(Date:5/22/2013)...  Grifols, ein globales Unternehmen der Gesundheitsbranche ... , Spanien, präsentierte die Ergebnisse einer Studie, ... PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des Alpha1-Proteins ... Niveau anhebt, das innerhalb des für gesunde ... eine lebensbedrohliche, genetische Erkrankung, bei der der ...
(Date:5/22/2013)... Israel , May 22, 2013 /PRNewswire/ ... leading developer and provider of microRNA-based molecular diagnostics, announces ... and Chief Executive Officer of Rosetta Genomics, will deliver ... taking place from June 3-6, 2013 in New York ... June 4 th at 2:00 p.m. Eastern time. ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of single and multiple drugs and drug metabolites in human urine...
For the qualitative detection of cardiac troponin I (cTnl) in human whole blood and serum specimens...
Medicine Products: